← All Posts
May 20, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
To elect 12 directors to the Board of Directors of Amgen for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: |
|
| 1a |
Dr. Wanda M. Austin |
✓ For(23.178)
|
| 1b |
Mr. Robert A. Bradway |
✗ Against(23.178)
|
| 1c |
Dr. Michael V. Drake |
✓ For(23.178)
|
| 1d |
Dr. Brian J. Druker |
✓ For(23.178)
|
| 1e |
Mr. Robert A. Eckert |
✓ For(23.178)
|
| 1f |
Mr. Greg C. Garland |
✓ For(23.178)
|
| 1g |
Mr. Charles M. Holley, Jr. |
✓ For(23.178)
|
| 1h |
Dr. S. Omar Ishrak |
✓ For(23.178)
|
| 1i |
Dr. Tyler Jacks |
✓ For(23.178)
|
| 1j |
Dr. Mary E. Klotman |
✓ For(23.178)
|
| 1k |
Ms. Ellen J. Kullman |
✓ For(23.178)
|
| 1l |
Ms. Amy E. Miles |
✓ For(23.178)
|
| 2 |
Advisory vote to approve our executive compensation. |
✓ For(23.178)
|
| 3 |
To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. |
✓ For(23.178)
|
| 4 |
Stockholder proposal to require an independent board chairman. |
✓ For(23.178)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial